281 related articles for article (PubMed ID: 26108134)
1. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies.
Cheungpasitporn W; Thongprayoon C; Kittanamongkolchai W; Srivali N; Edmonds PJ; Ungprasert P; O'Corragain OA; Korpaisarn S; Erickson SB
Ren Fail; 2015 Aug; 37(7):1237-41. PubMed ID: 26108134
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor use and risk of dementia: Systematic review and meta-analysis.
Li M; Luo Z; Yu S; Tang Z
Medicine (Baltimore); 2019 Feb; 98(7):e14422. PubMed ID: 30762748
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) Study.
Rooney MR; Bell EJ; Alonso A; Pankow JS; Demmer RT; Rudser KD; Chen LY; Lutsey PL
J Clin Gastroenterol; 2021 Sep; 55(8):677-683. PubMed ID: 33471493
[TBL] [Abstract][Full Text] [Related]
4. Risk Evaluation of Proton Pump Inhibitors for Panitumumab-Related Hypomagnesemia in Patients with Metastatic Colorectal Cancer.
Katsura H; Suga Y; Kubo A; Sugimura H; Kumatani K; Haruki K; Yonezawa M; Narita A; Ishijima R; Ikesue H; Toi H; Takata N
Biol Pharm Bull; 2024; 47(1):98-103. PubMed ID: 38171783
[TBL] [Abstract][Full Text] [Related]
5. Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence.
Ben-Eltriki M; Green CJ; Maclure M; Musini V; Bassett KL; Wright JM
Pharmacol Res Perspect; 2020 Oct; 8(5):e00651. PubMed ID: 32996701
[TBL] [Abstract][Full Text] [Related]
6. Gastric Cancer Risk in Patients with Long-Term Use of Proton Pump Inhibitors: A Systematic Review and Meta-Analysis of Observational and Interventional Studies.
Pan S; Thrift AP; Akhdar G; El-Serag HB
Dig Dis Sci; 2023 Sep; 68(9):3732-3744. PubMed ID: 37432532
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors associated with an increased risk of mortality in elderly: a systematic review and meta-analysis.
Song HJ; Seo HJ; Jiang X; Jeon N; Lee YJ; Ha IH
Eur J Clin Pharmacol; 2024 Mar; 80(3):367-382. PubMed ID: 38147074
[TBL] [Abstract][Full Text] [Related]
8. Association and Mechanisms of Proton Pump Inhibitors Use with Type-2 Diabetes Mellitus Incidence in Adults: A Systemic Review and Metaanalysis.
Chenchula S; Sharma P; Ghanta MK; Amerneni KC; Rajakarunakaran P; Saggurthi P; Chandra MB; Gupta R; Chavan M
Curr Diabetes Rev; 2024 Jan; ():. PubMed ID: 38243950
[TBL] [Abstract][Full Text] [Related]
9. Do proton pump inhibitors increase the risk of dementia? A systematic review, meta-analysis and bias analysis.
Ahn N; Nolde M; Krause E; Güntner F; Günter A; Tauscher M; Gerlach R; Meisinger C; Linseisen J; Baumeister SE; Rückert-Eheberg IM
Br J Clin Pharmacol; 2023 Feb; 89(2):602-616. PubMed ID: 36331350
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors reduce phlebotomy burden in patients with HFE-related hemochromatosis: a systematic review and meta-analysis.
Dirweesh A; Anugwom CM; Li Y; Vaughn BP; Lake J
Eur J Gastroenterol Hepatol; 2021 Oct; 33(10):1327-1331. PubMed ID: 32769410
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors, bone and phosphocalcic metabolism.
Philippoteaux C; Paccou J; Chazard E; Cortet B
Joint Bone Spine; 2024 Mar; 91(5):105714. PubMed ID: 38458487
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitors: Current Use and the Risk of Coronavirus Infectious Disease 2019 Development and its Related Mortality. Meta-analysis.
Toubasi AA; AbuAnzeh RB; Khraisat BR; Al-Sayegh TN; AlRyalat SA
Arch Med Res; 2021 Aug; 52(6):656-659. PubMed ID: 33814207
[TBL] [Abstract][Full Text] [Related]
13. Multiple electrolyte disorders triggered by proton pump inhibitor-induced hypomagnesemia: Case reports with a mini-review of the literature.
Souza CC; Rigueto LG; Santiago HC; Seguro AC; Girardi AC; Luchi WM
Clin Nephrol Case Stud; 2024; 12():6-11. PubMed ID: 38222324
[TBL] [Abstract][Full Text] [Related]
14. Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials.
Yang M; He Q; Gao F; Nirantharakumar K; Veenith T; Qin X; Page AT; Wong MCS; Huang J; Kuo ZC; Xia B; Zhang C; He Y; Meng W; Yuan J; Pan Y
BMC Med; 2021 Dec; 19(1):316. PubMed ID: 34856983
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis.
D'Silva KM; Mehta R; Mitchell M; Lee TC; Singhal V; Wilson MG; McDonald EG
Clin Microbiol Infect; 2021 Jan; ():. PubMed ID: 33465501
[TBL] [Abstract][Full Text] [Related]
16. Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis.
Alkhushaym N; Almutairi AR; Althagafi A; Fallatah SB; Oh M; Martin JR; Babiker HM; McBride A; Abraham I
Expert Opin Drug Saf; 2020 Mar; 19(3):327-334. PubMed ID: 31928106
[No Abstract] [Full Text] [Related]
17. Proton pump inhibitors and risk of gastrointestinal cancer: A meta‑analysis of cohort studies.
Tran TH; Myung SK; Trinh TTK
Oncol Lett; 2024 Jan; 27(1):28. PubMed ID: 38073768
[TBL] [Abstract][Full Text] [Related]
18. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.
Lambert AA; Lam JO; Paik JJ; Ugarte-Gil C; Drummond MB; Crowell TA
PLoS One; 2015; 10(6):e0128004. PubMed ID: 26042842
[TBL] [Abstract][Full Text] [Related]
19. A Case of Severe Proton Pump Inhibitor-Induced Hypomagnesemia Refractory to Continuous Oral and Intravenous Magnesium Replenishment.
Kheir K; Al Jassem O; El Koubayati G; Haddad F
Cureus; 2024 Feb; 16(2):e54483. PubMed ID: 38516446
[TBL] [Abstract][Full Text] [Related]
20. Osseous implications of proton pump inhibitor therapy: An umbrella review.
Alanazi AS; Almutairi H; Gupta JK; Mohanty D; Rath D; AlOdan AA; Mahal A; Khatib MN; Gaidhane S; Zahiruddin QS; Rustagi S; Satapathy P; Serhan HA
Bone Rep; 2024 Mar; 20():101741. PubMed ID: 38348455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
